Core Scientific, Inc. CORZ Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$798.36M+27.9% | -$1.11B-3.2% | -$1.07B+25.4% | ||
| $65.83M-4.5% | $68.91M-14.8% | $80.86M-13.3% | $93.22M-10.3% | $103.94M-8.2% | ||
| $99.81M+1.6% | $98.24M+4.2% | $94.27M+11.1% | $84.85M+22.7% | $69.17M+33.2% | ||
| -$23.31M-141% | -$9.68M-33.4% | -$7.25M-50.2% | -$4.83M-1,120% | -$396K+90.6% | ||
| $30.95M+187% | $10.78M+159% | -$18.25M-6.3% | -$17.17M-2.0% | -$16.83M-37.2% | ||
| -$36.47M-110% | -$17.4M-124% | $71.69M+87.0% | $38.35M+157% | $14.94M+695% | ||
| —— | —— | —— | —— | —— | ||
| $11.76M+4.4% | $11.27M-0.8% | $11.36M+18.8% | $9.57M+8.5% | $8.82M+27.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$606K-102% | $24.87M+21.9% | ||
| $573.17M+106% | $278.25M+100% | $138.99M+976% | $12.92M+153% | -$24.32M-157% | ||
| $1.03B+41.9% | $729M+50.9% | $482.95M+79.1% | $269.63M+83.4% | $147.05M+54.8% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | —— | —— | —— | —— | ||
| $6.09M+76.0% | $3.46M+79.4% | $1.93M+15.4% | $1.67M— | —— | ||
| —— | —— | —— | —— | $5M— | ||
| -$1.04B-40.2% | -$740.75M-49.3% | -$496.22M-81.7% | -$273.1M-79.4% | -$152.24M-59.9% | ||
| $995M— | $0+100% | -$20M— | —— | —— | ||
| —— | —— | —— | $285.08M-3.4% | $295.07M-3.2% | ||
| $2.26M+35.0% | $1.67M-29.8% | $2.38M-11.7% | $2.7M-9.9% | $2.99M-50.4% | ||
| —— | —— | —— | —— | —— | ||
| $912.48M+1,546% | -$63.1M-111% | $556.88M-25.2% | $744.43M-4.1% | $776.2M-7.0% | ||
| $447.26M+185% | -$525.6M-363% | $199.64M-58.8% | $484.24M-19.5% | $601.62M-23.3% | ||
| —— | —— | —— | —— | —— | ||
| -$27.47M+13.1% | -$31.6M-208% | $29.26M+61.7% | $18.1M+247% | -$12.28M-670% | ||
| —— | —— | -$4.4M+54.1% | -$9.58M+65.2% | -$27.51M+66.5% | ||
| —— | —— | —— | -$606K-102% | $24.87M+21.9% | ||
| $54.49M+139% | $22.79M-21.5% | $29.04M— | —— | —— | ||
| $11.76M+4.4% | $11.27M-0.8% | $11.36M+18.8% | $9.57M+8.5% | $8.82M+27.6% | ||
| $208.25M— | $0-100% | $71.56M-48.7% | $139.49M-44.1% | $249.65M-38.0% | ||
| —— | $0— | $0— | $0— | $0— | ||
| $192.39M-16.2% | $229.71M-19.1% | $283.81M-3.6% | $294.32M-14.1% | $342.74M-19.4% | ||
| —— | —— | —— | —— | $5M— | ||
| —— | —— | —— | —— | —— | ||
| —— | $0— | $0— | $0— | $0— | ||
| $6.09M+76.0% | $3.46M+79.4% | $1.93M+15.4% | $1.67M— | —— | ||
| $2.26M+35.0% | $1.67M-29.8% | $2.38M-11.7% | $2.7M-9.9% | $2.99M-50.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $6.73M-2.7% | $6.91M+46.5% | $4.72M-8.4% | $5.15M-0.1% | $5.15M+5.4% | ||
| —— | —— | —— | —— | —— | ||
| -$461.08M-2.3% | -$450.75M-31.0% | -$343.97M-34.0% | -$256.71M-49.8% | -$171.37M-229% | ||
| -$461.08M-2.3% | -$450.75M-31.0% | -$343.97M-34.0% | -$256.71M-49.8% | -$171.37M-229% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Core Scientific, Inc. generate?
- Core Scientific, Inc. (CORZ) generated $573.2M in operating cash flow over the trailing twelve months.
- What is Core Scientific, Inc.'s free cash flow?
- After $1.0B of capital expenditures, Core Scientific, Inc.'s free cash flow was -$461.1M over the trailing twelve months, down 169.1% year over year.
- Where does Core Scientific, Inc.'s cash flow data come from?
- Every line is extracted from Core Scientific, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
